Compared to Estimates, Celanese (CE) Q2 Earnings: A Look at Key Metrics

Celanese (CE) reported Q2 2025 results, with revenue of $2.53 billion and EPS of $1.44, both surpassing consensus estimates by 1.42% and 4.35% respectively, despite year-over-year declines of 4.5% in revenue and a significant drop in EPS from $2.38. Segment performance was mixed, with Engineered Materials net sales and EBITDA exceeding analyst expectations, while Acetyl Chain EBITDA missed estimates. The company's shares have significantly underperformed the broader market, returning -21.3% over the past month against the S&P 500's +2.7%, and currently hold a Zacks Rank #3 (Hold).

Analysis

Celanese (CE) reported mixed Q2 2025 results, characterized by headline beats on consensus estimates but significant year-over-year deterioration in core financial metrics. The company posted revenue of $2.53 billion and EPS of $1.44, surpassing analyst expectations by 1.42% and 4.35%, respectively. However, these figures represent a material decline from the prior year, with revenue down 4.5% and EPS falling sharply from $2.38. A deeper look at segment performance reveals a divergent story: the Engineered Materials division was a source of strength, with its Operating EBITDA of $326 million substantially outperforming the $278.5 million estimate. In contrast, the Acetyl Chain segment, despite a slight revenue beat, showed underlying weakness by missing its Operating EBITDA target ($260 million actual vs. $287.13 million estimate) and posting a steeper 7.2% year-over-year revenue decline. This operational weakness, coupled with the negative annual comparisons, appears to have heavily influenced market sentiment, as evidenced by the stock's -21.3% return over the past month, a stark underperformance against the S&P 500 composite's +2.7% gain.

Key Decisions for Investors

• Investors should look past the headline earnings beat and focus on the significant year-over-year declines in revenue and profitability, as well as the underlying weakness in the Acetyl Chain segment's EBITDA.
• The outperformance of the Engineered Materials segment is a key positive, and its continued strength should be monitored as a potential offset to challenges in other parts of the business.
• Given the stock's severe recent underperformance despite beating estimates, caution is warranted, as the market appears to be prioritizing the negative fundamental trends over the modest quarterly surprise.
• The Zacks Rank #3 (Hold) suggests a neutral near-term outlook, implying that investors may consider holding existing positions while awaiting clearer signs of a fundamental turnaround in year-over-year growth.